Upcoming FDA decision · December 18, 2026
DRUG PDUFA date: FDA decision expected December 18, 2026
126 days to goBRIGHT MINDS BIOSCIENCES INC. (DRUG) →
The FDA is expected to decide on this application from BRIGHT MINDS BIOSCIENCES INC. by the PDUFA target action date of December 18, 2026. NDA filing. Extracted from news: Camurus' NDA resubmission for CAM2029 in acromegaly accepted for review by the US FDA
A PDUFA date is the FDA's target deadline to complete its review of a drug application — approval, a complete response letter (CRL), or an extension are all possible. What is a PDUFA date? This page is research information, not financial advice.
December 18
Target action date
NDA
Stage
Detected
Date confidence
—
FDA designations